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ABSTRACT. Objective: This study employed a prospective design 
to examine the role of friend and partner relationship quality 1 year 
following substance use disorder treatment in the association between 
depressive symptoms at discharge from treatment and abstinence from 
substance use 2 years after treatment. Method: The sample consisted of 
1,453 male veterans who used alcohol and at least one other substance 
in the 3 months before treatment admission, who completed treatment, 
and who were abstinent from substances during the 2 weeks before 
discharge. Results: Fewer depressive symptoms at treatment discharge 
predicted better relationship quality with friends and a partner at 1-year 
follow-up, as well as abstinence from substance use at 2-year follow-up. 
Furthermore, friend and partner relationship quality at 1 year predicted 
abstinence from substance use at 2 years. Friend relationship quality 
at 1 year mediated part of the association between fewer depressive 
symptoms at treatment discharge and abstinence at 2-year follow-up. 
Conclusions: A stronger focus in treatment on reducing depressive 
symptoms and enhancing the quality of patients’ relationships with their 
friends and partner may increase the likelihood of long-term abstinence. 
(J. Stud. Alcohol Drugs, 72, 141-150, 2011)
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ALTHOUGH THERE IS GROWING INTEREST in the area, there still is relatively little defi nitive information 
about how personal and contextual variables contribute to 
abstinence or decreased risk for relapse following acute 
substance use disorder treatment. The high prevalence of 
relapse after treatment makes it especially important to iden-
tify protective factors that reduce the likelihood of return to 
problematic substance use. Several avenues of inquiry have 
highlighted personal and contextual factors implicated in in-
dividual differences in posttreatment outcome (Moos, 2007). 
We focus here on one personal factor (depressive symptoms) 
and two contextual factors (friend relationship quality and 
partner relationship quality), including their connections 
with one another and with abstinence from substance use 
after treatment.
Depressive symptoms and friend and partner relationship 
quality
 It has been theorized that depressed individuals create 
stress and discord in their relationships, which in turn in-
crease the likelihood of heightened distress and depression in 
the future (Hammen, 1991, 1999, 2006; Holahan et al., 2005; 
Potthoff et al., 1995). According to such theory, individuals 
experiencing depressive symptoms should have less harmo-
nious, or more confl icted, friend and partner relationships. 
In fact, there is substantial evidence that adults and children 
with higher levels of depressive symptoms have lower qual-
ity relationships characterized by rejection and dissatisfac-
tion (e.g., Gotlib and Lee, 1989; Joiner et al., 1992, 1993; 
reviewed in Joiner, 2002; see also Chan and Poulin, 2009; 
Rudolph et al., 2007). There is also an inverse relation be-
tween level of depressive symptoms and amount of marital 
satisfaction (Kouros et al., 2008).
 Existing literature has primarily considered the positive 
association between higher levels of depressive symptoms 
and interpersonal problems. An alternative competence-driv-
en perspective that focuses on the association between lower 
levels of depressive symptoms and better interpersonal rela-
tionships is also valuable in that it may identify mechanisms 
underlying healthy adaptation or positive change following 
intervention. In one such study, Beach and O’Leary (1992) 
showed that women’s satisfaction with their relationship to 
their partner mediated the link between pretreatment to post-
treatment decreases in depressive symptoms. Several other 
142 JOURNAL OF STUDIES ON ALCOHOL AND DRUGS / JANUARY 2011
investigations have shown an association between decreased 
levels of depressive symptoms and higher marital satisfac-
tion (Davila et al., 2003; see also Fagan, 2009).
 Here, we extend prior work by examining the connec-
tion between the level of depressive symptoms at treatment 
discharge and the quality of relationships with friends and 
partner at a 12-month follow-up.
Friend and partner relationship quality and posttreatment 
abstinence
 Social support from friends and partners has been 
positively associated with higher rates of posttreatment 
abstinence (e.g., Beattie and Longabaugh, 1999; Heinz et 
al., 2009; McKay et al., 2001). The key contributing factors 
to this association appear to be cohesion, clarity regarding 
abstinence messages and norms, and abstinence-specifi c and 
general support (Beattie and Longabaugh, 1997; Bond et al., 
2003). Not surprisingly, friends who foster involvement in 
rewarding activities, play a monitoring role for the patient, 
and abstain from substances themselves act as healthy role 
models and provide the support that contributes to an in-
creased likelihood of sustained recovery (Moos, 2007).
 Higher levels of marital satisfaction also have been re-
lated to better treatment outcomes (Beattie, 2001; McCrady 
et al., 2002, 2004). More generally, a stable relationship with 
a partner and more family support have been positively as-
sociated with abstinence and tend to protect against relapse 
to substance use (McKay et al., 2001; Walton et al., 2002). 
Conversely, an earlier analysis of part of the sample used 
here found that patients who reported more stressful relation-
ships with their spouse or partner at entry to treatment were 
more likely to continue to drink and to experience substance 
use problems after treatment (Tracy et al., 2005).
 We extend this body of work here by focusing on how a 
reduction in patients’ depressive symptoms during treatment 
affects subsequent friend and partner relationship quality 
and, in turn, how the quality of these relationships foreshad-
ows patients’ posttreatment abstinence.
Depressive symptoms and abstinence from substances after 
treatment
 There is a close association between depressive symptoms 
and substance misuse; one estimate suggests that up to 80% 
of individuals with alcohol use disorders report signifi cant 
depressive symptoms (Daeppen et al., 2000). Experience 
sampling and daily diary methods have shown a positive as-
sociation between sadness and the likelihood of alcohol use 
(Armeli et al., 2000). Moreover, depressive symptoms seem 
to exacerbate substance-related problems among marijuana 
(Milich et al., 2000) and polydrug (e.g., individuals using 
both cocaine and alcohol) users (R. A. Brown et al., 1998).
 More importantly, depressive symptoms have been 
positively associated with posttreatment substance use. For 
example, Kodl and coworkers (2008) found that, compared 
with individuals who did not have signifi cant depressive 
symptoms, individuals with signifi cant depressive symp-
toms were more likely to return to drinking after treatment. 
In fact, higher levels of depressive symptoms at entry into 
treatment have been prospectively related to a lower likeli-
hood of abstinence at discharge (R. A. Brown et al., 1998; 
Dodge et al., 2005). Furthermore, negative emotional states 
are cited as the most frequent precipitant of relapse follow-
ing remission from substance dependence (Hodgins et al., 
1995; Witkiewitz and Marlatt, 2006) and are related to a 
greater severity and longer duration of fi rst relapse (Zywiak 
et al., 1996).
 Although it is intuitively appealing, much less attention 
has focused on whether a decline in symptoms of depression 
during treatment is associated with a higher likelihood of 
posttreatment abstinence, an issue we address here. In this 
regard, depressive symptoms are likely to decrease among 
men during substance use treatment (R. A. Brown et al., 
1998; S. A. Brown et al., 1995; Brown and Schuckit, 1988). 
To the extent that depressive symptoms elicit substance mis-
use because of self-medication and the use of substances to 
reduce distress (Greeley and Oei, 1999), fewer depressive 
symptoms at treatment discharge should be associated with 
a higher likelihood of abstinence.
A model linking depressive symptoms, relationship quality, 
and abstinence
 Based on a synthesis and proposed extension of the litera-
ture, we formulated a model linking depressive symptoms, 
relationship quality, and abstinence from substances after 
treatment (Figure 1). Prior literature suggests that there is an 
inverse association between depressive symptoms and friend 
and partner relationship quality (Path A). In addition, friend 
and partner relationship quality and depressive symptoms 
have been implicated in abstinence following treatment for 
substance use disorders (Paths B and C in Figure 1). We 
extend prior work here by integrating these conceptually 
related areas of research into a prospective model of the 
determinants of abstinence.
 We expected that lower levels of depressive symptoms 
at discharge from acute treatment would predict improved 
friend and partner relationship quality 12 months after treat-
ment (Path A). Furthermore, we expected that improved 
relationship quality 12 months after treatment and lower 
levels of depressive symptoms at treatment discharge would 
be positively related to abstinence from substances 24 
months after treatment (Paths B and C). Finally, we expected 
increases in relationship quality to act as one mechanism 
by which lower levels of depressive symptoms would lead 
to abstinence. Specifi cally, we hypothesized that 12-month 
relationship quality with friends and a partner would mediate 
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the association between depressive symptoms immediately 




 A total of 1,828 male patients (Mage = 39.41 years, SD 
= 7.27) who used alcohol and at least one other drug (e.g., 
marijuana, cocaine) in the 3 months before admission to 
one of 15 Veterans Affairs (VA) residential substance use 
treatment programs were included. These patients completed 
treatment and were abstinent from alcohol and other drugs 
during the 2 weeks before discharge. The current sample 
was part of a larger VA-approved treatment evaluation study 
of male patients with substance use disorders (Finney et al., 
2001). In terms of ethnicity, more than half of the patients 
were African American/Black (63.4%) and slightly less than 
one third (32.2%) were White. The remaining patients were 
Hispanic or Latino (2.8%), Native American (1.0%), Asian 
(0.1%), and “other” (0.5%).
 On admission to the program and based on the Interna-
tional Classifi cation of Diseases–Ninth Revision (ICD-9-
CM; United States National Center for Health Statistics, 
1988), trained clinicians evaluated patients for current Axis-I 
diagnoses. A total of 10.9% were diagnosed with alcohol 
abuse/dependence only; 67.2% were diagnosed with both 
drug and alcohol abuse/dependence; and, although they 
were using alcohol, 18.7% were diagnosed with drug abuse/
dependence only.
Measures
 Depressive symptoms (α = .88) were assessed at treat-
ment intake and discharge by the mean of six, 5-point Likert 
items (0 = not at all to 4 = extremely) drawn from the Brief 
Symptom Inventory (Derogatis and Melisaratos, 1983). 
The items tapped the patient’s mood (e.g., “Feeling hope-
less about the future” or “Feeling lonely even when you are 
with people”) in the 3 months before admission and the 2 
weeks before discharge. The Brief Symptom Inventory is a 
well-established, psychometrically sound measure that has 
been used extensively in prior research, including research 
with individuals who have alcohol and/or drug use disorders 
(e.g., Buckner and Mandell, 1990; Derogatis and Fitzpatrick, 
2004; Derogatis and Savitz, 2000; Preston and Harrison, 
2003).
 Patient-friend and patient-partner relationship quality 
were assessed with the Life Stressors and Social Resources 
Inventory (LISRES; Moos and Moos, 1994). The LISRES 
produces an overall score for friend and for partner (defi ned 
FIGURE 1.    Proposed model of depressive symptoms, friend and partner relationship quality, and posttreatment abstinence from substance use
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as current spouse/partner) relationship quality that ranges 
from 0 to 44 and has two components: (a) The interpersonal 
resources subscale (α = .90 for friend and .88 for partner 
relationships) is comprised of six items rated on 5-point 
Likert-type scales (0 = never to 4 = often). Sample items in-
clude “Can you count on her/him to help you when you need 
it?” and “Does she/he cheer you up when you are sad or 
worried?” (b) The interpersonal stressors subscale (α = .73 
for friend and .76 for partner relationships) is comprised of 
fi ve items employing an identical 5-point Likert-type scale. 
Sample items include “Is she/he critical or disapproving of 
you?” and “Does she/he get angry or lose her/his temper 
with you?” The LISRES has good psychometric qualities 
(Moos and Moos, 1994; Tracy et al., 2005) and has been 
used extensively in prior work to assess relationship quality 
among individuals with substance use disorders (e.g., Bren-
nan et al., 1999; Humphreys et al., 1999; Tracy et al., 2005).
 Frequency of alcohol and drug use was assessed at intake, 
discharge, and 24-month follow-up with a measure derived 
from the Treatment Outcome Prospective Study (TOPS; 
Hubbard et al., 1989). Participants indicated, on a 5-point 
Likert-type scale (0 = never to 4 = every day), the frequency 
of their substance use in the past 3 months at intake and 
24-month follow-up and in the past 2 weeks at discharge. 
In the current study, frequencies of beer, wine, and distilled 
spirit use at intake were summed to create a composite 
alcohol use frequency score (range: 0-12). Furthermore, 
drug use frequencies from each of 16 measured drugs (e.g., 
cocaine, marijuana, heroin, amphetamines, barbiturates, and 
hallucinogens) were summed to compute a composite drug 
use frequency score (range: 0-64).
Procedure
 All patients provided informed consent. Patients re-
ported on their depressive symptoms and substance use at 
admission to treatment and just before discharge. Patients 
completed the measures of friend and partner relationship 
quality at admission to treatment and again at a 12-month 
follow-up, and they completed the substance use measure 
again at a 24-month follow-up. Twelve and 24-month follow-
up assessments were primarily completed by mail (93.7% at 
12 months), with the remainder of participants completing 
the questionnaires via telephone or during an in-person visit 
(Finney et al., 2001).
 In general, the programs ranged in length from 21 to 28 
days, were staffed by a multidisciplinary team, and employed 
both individual and group therapy. Patients completed de-
toxifi cation before treatment admission. Treatments varied 
but generally included 12-step, cognitive-behavioral, and 
combined (12-step and cognitive-behavioral) treatment ap-
proaches. There were no signifi cant differences in outcomes 
between patients who did and those who did not complete 
the full treatment protocol (Ouimette et al., 1997). The pro-
grams referred patients to outpatient continuing care and 
community-based self-help groups following discharge (for 
more information about the characteristics of the treatment 
programs, see Finney et al., 2001).
Results
 A total of 1,453 of the 1,828 patients (79.5%) who were 
assessed at baseline were reassessed at both the 12- and 
24-month follow-ups. T test analyses revealed no signifi cant 
differences in terms of participant age, ethnic background, 
or frequency of alcohol or drug use at intake between indi-
viduals who completed the 12- and 24-month follow-ups and 
those who did not (p > .05). A total of 513 of the 1,453 pa-
tients who were followed at 12 and 24 months had a spouse 
or partner. Thus, the following analyses are based on an n 
of 1,453 for friend relationship quality and an n of 513 for 
partner relationship quality.
 In terms of prior treatment, 52.9% (n = 769) of the pa-
tients who were followed at 12 and 24 months (n = 1,453) 
reported residential treatment and 28.4% (n = 413) reported 
outpatient treatment for an alcohol or drug use problem 
during the 2 years before intake. At intake, 79.2% of the 
patients reported drinking beer, 48.2% reported drinking 
distilled spirits, and 27.7% reported drinking wine at least 
weekly during the 3 months before admission. Regarding 
other substance use before intake, 76.7% of participants 
reported cocaine use, 64.3% reported marijuana use, 8.3% 
reported amphetamine use, 8.3% reported injection heroin 
use, 5.4% reported barbiturate use, and 3.3% reported 
hallucinogen use. At 24 months following discharge from 
treatment, 36.5% of the patients reported abstinence from 
alcohol and drugs. On average, patients reported moderate 
depressive symptoms during the 3 months before admission 
and mild depressive symptoms during the 2 weeks before 
discharge (Table 1).
 There was an inverse relation between patient-reported 
depressive symptoms at discharge and 12-month friend and 
partner relationship quality. Better 12-month friend and part-
ner relationship quality were positively and signifi cantly re-
lated to 24-month abstinence from substances (see Table 1).
Friend relationship quality regression analyses
 A logistic regression was conducted to examine Path C in 
the model, that is, the relation between depressive symptoms 
at discharge (the predictor) and 24-month abstinence (the 
criterion: 1 = abstinence [defi ned as no alcohol or drug use 
in the past 3 months], 0 = relapse [defi ned as any alcohol 
or drug use in the past 3 months]). Alcohol and drug use at 
intake as well as intake depressive symptoms were covariates 
at Step 1 of the model, and discharge depressive symptoms 
were entered at Step 2. Step 1 of the model revealed no 
signifi cant predictors of 24-month abstinence. In Step 2, 
 MCKEE, BONN-MILLER, AND MOOS 145
fewer discharge depressive symptoms predicted 24-month 
abstinence from substance use (see Analysis 1 in Table 2).
 As a test of Path A, a hierarchical linear regression was 
conducted to examine the association between depressive 
symptoms at discharge (the predictor) and friend relationship 
quality at 12-month follow-up (the criterion). Intake friend 
relationship quality was positively associated with 12-month 
friend relationship quality, whereas depressive symptoms 
at intake were negatively associated with 12-month friend 
relationship quality. In the second step of the model, fewer 
depressive symptoms at discharge were signifi cantly associ-
ated with increased 12-month friend relationship quality (see 
Analysis 2 in Table 2), contributing 2.3% of unique variance 
in prediction of 12-month friend relationship quality.
 Next, a logistic regression was conducted to examine Path 
B in the model, that is, the link between 12-month friend 
relationship quality (the predictor) and 24-month substance 
use abstinence (the criterion: 1 = abstinence, 0 = relapse). 
Alcohol and drug use at intake, intake friend relationship 
quality, and depressive symptoms at intake and discharge 
were included as covariates at Step 1; 12-month friend rela-
tionship quality was entered at Step 2. Step 1 of the model 
revealed that fewer discharge depressive symptoms signifi -
cantly predicted a higher likelihood of 24-month abstinence. 
In Step 2, better 12-month friend relationship quality signifi -
cantly contributed to the prediction of 24-month abstinence 
(see Analysis 3 in Table 2).
Mediation analyses
 The procedure proposed by Kenny et al. (1998) was 
employed to test for mediation (see Table 2). As shown 
earlier, there was a signifi cant negative association between 
the predictor (discharge depressive symptoms) and criterion 
(24-month substance abstinence) (Path C; see Analysis 1 in 
Table 2). Next, the predictor (discharge depressive symp-
toms) was inversely related to 12-month friend relationship 
quality (the mediator), after accounting for the original 
covariates (Path A; see Analysis 2 in Table 2). In addition, 
after controlling for the predictor (discharge depressive 
symptoms) and original covariates in Step 1, the proposed 
mediator (12-month friend relationship quality) was posi-
tively related to the outcome (24-month abstinence; Path 
B; see Analysis 3 in Table 2). Finally, the relation between 
discharge depressive symptoms and 24-month substance 
use abstinence was rendered insignifi cant (odds ratio [OR] 
= 0.94 vs. 0.82, respectively) by the inclusion of 12-month 
friend relationship quality in the model, indicating partial 
mediation (Path C′; see Analysis 4 in Table 2).
Partner relationship quality regression analyses
 The analyses of partner relationship quality used a subset 
of the total sample (n = 513) who reported having a partner 
at both intake and 12-month follow-up and who were fol-
lowed at 24 months. To focus on Path C in the model, a 
logistic regression was conducted to examine the relation 
between depressive symptoms at discharge (the predictor) 
and 24-month abstinence (the criterion: 1 = abstinence, 0 
= relapse). Alcohol and drug use at intake and intake de-
pressive symptoms were covariates at Step 1 of the model, 
and discharge depressive symptoms were entered at Step 
2. Step 1 of the model revealed no signifi cant predictors of 
24-month substance use abstinence. In Step 2, discharge 
depressive symptoms did not predict 24-month abstinence 
from substance use above and beyond the variance accounted 
TABLE 1. Descriptive data and zero-order relations among indices of alcohol and drug use, depressive symptoms, and friend and partner 
relationship quality
Variable name 1 2 3 4 5 6 7 8 9 M (SD)
1. Intake alcohol use – .23** .21** .15** -.12** -.09* -.16** -.08* -.03 5.30 (2.76)
2. Intake drug use – – .15** .13** -.10** -.04 -.07** -.06 -.04 4.67 (4.03)
3. Intake depressive symptoms – – – .44** -.29** -.31** -.18** -.18** .02 1.93 (0.97)
4. Discharge depressive symptoms – – – – -.18** -.20** -.23** -.28** -.05 0.89 (0.76)
5. Intake friend quality – – – – – .35** .36** .23** -.03 23.95 (6.92)
6. Intake partner quality – – – – – – .22** .33** .01 25.65 (7.76)
7. 12-month friend quality – – – – – – – .51** .27** 26.14 (7.50)
8. 12-month partner quality – – – – – – – – .27** 28.22 (8.08)
9. 24-month substance abstinence – – – – – – – – – 36.5% abstinent
Notes: Correlations were calculated based on the sample of 1,453 patients. (1) Intake alcohol use = a summed composite of beer, wine, and 
distilled spirits use frequency at intake (range: 0-12); (2) intake drug use = a summed composite of drug use frequencies from each of the 
16 measured drugs (range: 0-64); (3) intake depressive symptoms = mean depressive symptoms at intake as measured by six items from the 
Brief Symptom Inventory (BSI) (range: 0-4); (4) discharge depressive symptoms = mean depressive symptoms at discharge as measured 
by six items from the BSI (range: 0-4); (5) intake friend quality = friend relationship quality as measured by the Life Stressors and Social 
Resources Inventory (LISRES) at intake (range: 0-44); (6) intake partner quality = spouse/partner relationship quality as measured by the 
LISRES at intake (range: 0-44); (7) 12-month friend quality = friend relationship quality as measured by the LISRES at 12-month follow-up 
(range: 0-44); (8) 12-month partner quality = spouse/partner relationship quality as measured by the LISRES at 12-month follow-up (range: 
0-44); (9) 24-month substance abstinence = substance use abstinence at 24-month follow-up (1 = abstinence [defi ned as no alcohol or drug 
use in the past 3 months]; 0 = relapse [defi ned as any alcohol or drug use in the past 3 months]).
*p < .05; **p < .01.
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for by the variables entered at Step 1 (see Analysis 1 in 
Table 3).
 To focus on Path A in the model, a hierarchical linear 
regression examined the association between depressive 
symptoms at discharge (the predictor) and partner relation-
ship quality at 12-month follow-up (the criterion). Partner 
relationship quality and depressive symptoms at intake 
signifi cantly predicted 12-month partner relationship quality 
at Step 1; intake relationship quality was positively associ-
ated with 12-month relationship quality, whereas depressive 
symptoms were inversely associated with 12-month rela-
tionship quality. In Step 2 of the model, fewer depressive 
symptoms at discharge were signifi cantly associated with 
increased 12-month partner relationship quality (see Analy-
sis 2 in Table 3), contributing 2.8% of unique variance in 
prediction of 12-month partner relationship quality.
 Finally, a logistic regression was conducted to examine 
Path B, that is, the relation between 12-month partner re-
lationship quality (the predictor) and 24-month abstinence 
(the criterion: 1 = abstinence, 0 = relapse). Alcohol and 
drug use at intake, intake partner relationship quality, and 
depressive symptoms at intake and discharge were included 
as covariates at Step 1, and 12-month partner relationship 
quality was entered at Step 2. Step 1 of the model revealed 
no signifi cant predictors of 24-month abstinence. In Step 2, 
higher levels of 12-month partner relationship quality signifi -
cantly contributed to the prediction of 24-month abstinence 
from substance use (see Analysis 3 in Table 3). As discharge 
depressive symptoms were not signifi cantly associated 
with 24-month abstinence from substance use (Path C), no 
mediation analyses were conducted for partner relationship 
quality.
Subsidiary analyses
 Controlling for program treatment orientation and af-
tercare. Preliminary analyses showed that patients who 
attended 12-step treatment programs were more likely to 
be abstinent at 24 months than were patients who attended 
cognitive-behavioral or combined programs, χ2(1, n = 1,453) 
= 22.72, p < .01. Accordingly, we repeated the main analyses 
controlling for treatment program orientation (1 = 12 step, 
0 = cognitive-behavioral or combined). This control did not 
affect any of the associations between the primary predictors 
and the criteria.
 Because patients were encouraged to engage in continu-
ing outpatient care and to attend 12-step self-help groups 
following treatment, we conducted subsidiary analyses con-
trolling for (a) the number of individual or group substance 
use and psychiatric treatment sessions patients attended dur-
ing the year before the time point of the criterion variable or 
(b) the number of 12-step self-help group sessions attended 
during the 3 months before the time point of the criterion 
variable (i.e., 12-month follow-up when the criterion was 
TABLE 2. Regression analyses testing the role of friend relationship quality in the association between discharge 
depressive symptoms and 24-month abstinence from substance use
  Exp(B)
Independent variable(s) Dependent variable or β t or [CI]
a1. Intake alcohol use (Step 1) 24-month abstinence 0.98 [0.94, 1.02]
 Intake drug use (Step 1)  0.98 [0.96, 1.01]
 Intake depressive symptoms (Step 1)  1.08 [0.96, 1.20]
 Discharge depressive symptoms (Step 2)  0.82 [0.70, 0.96]*
b2. Intake friend quality (Step 1) 12-month friend quality 0.34 13.20**
 Intake depressive symptoms (Step 1)  -0.08 -3.23**
 Discharge depressive symptoms (Step 2)  -0.17 -6.39**
a3. Intake alcohol use (Step 1) 24-month abstinence 0.98 [0.94, 1.02]
 Intake drug use (Step 1)  0.98 [0.96, 1.01]
 Intake friend quality (Step 1)  0.99 [0.98, 1.01]
 Intake depressive symptoms (Step 1)  1.13 [1.00, 1.28]
 Discharge depressive symptoms (Step 1)  0.82 [0.69, 0.96]**
 12-month friend quality (Step 2)  1.10 [1.08, 1.12]**
a4. Intake alcohol use (Step 1) 24-month abstinence 1.00 [0.95, 1.04]
 Intake drug use (Step 1)  0.98 [0.95, 1.01]
 Intake depressive symptoms (Step 1)  1.11 [0.98, 1.26]
 Intake friend quality (Step 1)  0.96 [0.94, 0.98]**
 12-month friend quality (Step 1)  1.10 [1.09, 1.12]**
 Discharge depressive symptoms (Step 2)  0.94 [0.80, 1.12]
Notes: n = 1,453. Exp(B) = odds ratio provided for binary logistic regression; β = standardized beta weight 
provided for hierarchical multiple regression; t = t statistic provided for hierarchical multiple regression; CI = 
confi dence interval provided for binary logistic regression. aBinary logistic regression; bhierarchical multiple 
regression.
*p < .05; **p < .01.
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12-month relationship quality and 24-month follow-up when 
the criterion was 24-month abstinence). Group-based treat-
ment for a substance use disorder signifi cantly predicted 
a higher likelihood of 24-month abstinence; 12-step self-
help group attendance signifi cantly predicted better friend 
and partner relationship quality and a higher likelihood of 
24-month abstinence. However, the associations between the 
primary predictors and the criteria remained the same after 
controlling for group-based substance use treatment sessions 
and 12-step self-help group attendance.
 Examining interpersonal resources and interpersonal 
stressors. We also conducted subsidiary analyses with 
each of the two subscales that comprise the total friend 
relationship quality score (i.e., interpersonal resources 
subscale and interpersonal stressors subscale) to exam-
ine the associations between depressive symptoms, the 
potential positive and negative aspects of friendship, and 
24-month abstinence from substance use. With regard 
to friend resources, which captures the general tendency 
for a friend to offer instrumental and emotional support, 
fewer discharge depressive symptoms predicted increased 
12-month friend interpersonal resources, above and be-
yond the initial covariates (Path A; β = -.14; p < .01). In 
essence, patients with lower levels of depressive symptoms 
at discharge were more likely to describe friends as sup-
portive at the 12-month assessment. In turn, increased 
12-month friend resources were positively associated 
with 24-month abstinence, after accounting for the vari-
ables in Step 1 of the model (Path B; OR = 1.13, 95% 
CI [1.11-1.16], p < .01). Finally, there was a signifi cant 
reduction in the relation between discharge depressive 
symptoms and 24-month abstinence after the introduction 
of 12-month friend interpersonal resources (OR = 0.82 vs. 
0.92), indicating that friend resources mediated part of the 
association between discharge depressive symptoms and 
24-month abstinence (Path C′).
 Turning to friend interpersonal stressors, measured by a 
subscale assessing the general tendency for a friend to be 
negative, hostile, or angry, fewer discharge depressive symp-
toms predicted fewer 12-month friend interpersonal stress-
ors, above and beyond the initial covariates (Path A; β = .14; 
p < .01). Fewer 12-month friend interpersonal stressors were 
associated with 24-month substance use abstinence, after 
accounting for the variables in Step 1 of the model (Path B; 
OR = 0.92, 95% CI [0.89-0.95], p < .01). However, there 
was a nonsignifi cant reduction in the association between 
discharge depressive symptoms and 24-month abstinence 
after introduction of friend stressors (OR = 0.82 vs. 0.86), 
indicating that these stressors did not mediate the relation 
between discharge depressive symptoms and 24-month ab-
stinence (Path C′).
Discussion
 We examined the role of friend and partner relationship 
quality 12 months following substance use treatment in the 
association between depressive symptoms at treatment dis-
charge and abstinence from substance use 24 months after 
treatment. In brief, lower levels of depressive symptoms at 
discharge were associated with an increase in friend and 
partner relationship quality at a 12-month follow-up. In 
turn, improved friend and partner relationship quality at 12 
months was associated with a higher likelihood of 24-month 
abstinence from substance use. Moreover, improved friend 
TABLE 3. Regression analyses testing the role of partner relationship quality in the association between dis-
charge depressive symptoms and 24-month abstinence from substance use
  Exp(B)
Independent variable(s) Dependent variable or β t or [CI]
a1. Intake alcohol use (Step 1) 24-month abstinence 1.00 [0.93, 1.08]
 Intake drug use (Step 1)  0.98 [0.94, 1.03]
 Intake depressive symptoms (Step 1)  0.89 [0.73, 1.09]
 Discharge depressive symptoms (Step 2)  0.82 [0.61, 1.11]
b2. Intake partner quality (Step 1) 12-month partner quality 0.29 6.76**
 Intake depressive symptoms (Step 1)  -0.14 -3.34**
 Discharge depressive symptoms (Step 2)  -0.21 -4.61**
a3. Intake alcohol use (Step 1) 24-month abstinence 1.01 [0.94, 1.08]
 Intake drug use (Step 1)  0.99 [0.94, 1.03]
 Intake partner quality (Step 1)  1.00 [0.98, 1.03]
 Intake depressive symptoms (Step 1)  0.95 [0.76, 1.19]
 Discharge depressive symptoms (Step 1)  0.83 [0.61, 1.12]
 12-month partner quality (Step 2)  1.10 [1.07, 1.14]**
Notes: n = 513. Exp(B) = odds ratio provided for binary logistic regression; β = standardized beta weight 
provided for hierarchical multiple regression; t = t statistic provided for hierarchical multiple regression; CI = 
confi dence interval provided for binary logistic regression. aBinary logistic regression; bhierarchical multiple 
regression.
*p < .05; **p < .01.
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relationship quality mediated part of the association between 
reduced depressive symptoms at discharge and 24-month 
abstinence.
 After accounting for intake alcohol and drug use and de-
pressive symptoms, we found that lower levels of depressive 
symptoms at treatment discharge were related to 24-month 
abstinence from substance use in the overall sample of 
patients, that is, those who reported on friend relationship 
quality at intake and 12 months. This fi nding is consistent 
with prior studies that have identifi ed depressive symptoms 
as a salient risk factor for relapse (R. A. Brown et al., 1998; 
Dodge et al., 2005; Kodl et al., 2008) and extends this litera-
ture by showing that lower levels of depression posttreatment 
bolster the likelihood of successful abstinence as long as 2 
years later.
 Although there was an inverse association between de-
pressive symptoms and 24-month abstinence among the 
more restricted set of patients who had a partner at intake 
and 12-month follow-up, this association was not statisti-
cally signifi cant. Secondary analyses revealed that a possible 
explanation for the differences in the signifi cance of Path C 
between the two subgroups lies in the signifi cant group dif-
ference in intake depression scores. Here, a Brown-Forsythe 
test, used because of the unequal group sizes, revealed that 
patients with partners (n = 513) reported signifi cantly lower 
levels of depression at discharge compared with patients 
without partners (n = 940), Brown-Forsythe (1, 1135.33) = 
20.40, p < .01. This difference highlights a possible buffering 
effect for individuals with partners in terms of depressive 
symptoms, thus providing a more restricted range of depres-
sive symptoms from which to improve.
 After controlling for friend relationship quality and de-
pressive symptoms at intake, fewer depressive symptoms at 
discharge were associated with increased friend relationship 
quality 12 months following treatment, which was associated 
with a higher likelihood of abstinence at 24 months. These 
fi ndings support prior studies that highlight the detrimental 
infl uence of depressive symptoms on the quality of inter-
personal relationships (e.g., Gotlib and Lee, 1989; Joiner et 
al., 1992, 1993; reviewed in Joiner, 2002). In addition, they 
add to prior work on the positive infl uence of a supportive 
social network on sobriety (Bond et al., 2003; Litt et al., 
2009) by emphasizing the importance of the quality of peer 
relationships.
 We also found that friend relationship quality 12 months 
after treatment explained (mediated) part of the association 
between discharge depressive symptoms and abstinence at 
24 months. These fi ndings identify friend relationship qual-
ity as a potentially malleable protective factor that can be 
targeted and bolstered to improve abstinence rates following 
treatment. Future work could benefi t from replicating and 
extending the current fi ndings with prospective monitoring 
of friend relationships during treatment and follow-up, as 
well as by obtaining “real-time” information about other 
contributors to abstinence.
 Subsidiary analyses indicated that the partial mediation 
effect of the quality of friend relationships was the result of 
positive aspects of the friendship, such as emotional sup-
port, rather than interpersonal stressors in the friendship, 
such as hostility and anger. Thus, a focus on increasing the 
likelihood that friends can and will offer consistent support 
may be the most important target for interventions aimed 
at increasing abstinence rates. Such a focus is consistent 
with fi ndings on 12-step self-help groups that highlight the 
benefi ts of a wide network of social support for continued 
abstinence (Moos, 2008).
 In terms of partner relationship quality, fewer depressive 
symptoms at treatment discharge were associated with im-
proved partner relationship quality at 12-month follow-up, 
and, in turn, 12-month partner relationship quality predicted 
24-month abstinence from substance use. These data add to 
the body of work indicating that decreased depressive symp-
toms are related to higher marital satisfaction (Davila et al., 
2003; Kouros et al., 2008).
 The fi ndings are also consistent with work showing an 
association between higher partner relationship quality and 
reduced substance use (McCrady et al., 2002; Tracy et al., 
2005). In this regard, spousal involvement in treatment for 
problematic substance use can enhance treatment outcomes 
and prevent relapse (Baucom et al., 1998). Regardless of 
whether partners are included in treatment, our results sug-
gest that the partner relationship may be enhanced when 
patients’ levels of depressive symptoms decline. Future 
work could benefi t from replicating and extending the cur-
rent fi ndings by examining the contribution of other familial 
relationships (e.g., siblings, parents, children, extended kin) 
to the current model.
 A number of limitations of the study qualify the present 
fi ndings. First, the homogeneity of the sample, in terms of 
gender and veteran status, limits the generalizability of the 
results. Although the all-male sample precludes broad state-
ments about the fi ndings, it is noteworthy that depressive 
symptoms are an integral component of the model tested. 
Given that women are twice as likely to be diagnosed with 
depression and tend to score higher on measures of depres-
sive symptoms than men (Kessler et al., 1993; Nolen-Hoek-
sema, 1987), much of the literature examining the relations 
between depressive symptoms and psychosocial outcomes 
has focused on women (Addis, 2008). The current study, 
then, adds to a growing literature that recognizes the impor-
tance of including men in efforts to delineate the correlates 
of depression, particularly among a population characterized 
by problematic alcohol and drug use. Nonetheless, it remains 
an important empirical question as to whether the same rela-
tions would hold among a sample inclusive of women.
 Second, because single-respondent self-report measures 
were used as the primary assessment strategy, the results are 
 MCKEE, BONN-MILLER, AND MOOS 149
not fully protected against reporting errors. To address these 
points, future studies could use a multiple-respondent assess-
ment strategy (e.g., reporting from both patient and partner) 
and examine the contribution of relationship quality and 
depressive symptoms to abstinence in more diverse samples. 
In addition, although the measures employed here to deter-
mine levels of alcohol/drug use and depressive symptoms are 
widely used, more comprehensive measures of substance use 
(e.g., multiple daily use, drug potency) should be included 
in future research. Use of a more comprehensive measure-
ment approach could extend beyond the current dichotomous 
abstinence fi ndings to a more nuanced model of the relations 
among depression, relationship quality, and substance use 
at treatment follow-up. Finally, it is important to note that 
some signifi cant interrelations in the current investigation are 
small in magnitude. Future work would benefi t from testing 
whether these signifi cant relationships, which were modest 
in the present study, replicate in other samples (e.g., women, 
women and men in outpatient treatment settings).
 Overall, our fi ndings add to the literature on the role of 
depressive symptoms and partner and friend relationship 
quality in predicting abstinence. The fi ndings are consistent 
with a social context perspective that highlights the potential 
for strengthening the individual’s microsystem (i.e., friends 
and partner) and reducing the likelihood of relapse by bol-
stering protective factors (e.g., interpersonal resources) and 
reducing risk factors (e.g., chronic relationship stress). Our 
results suggest that lower depressive symptoms contribute to 
posttreatment abstinence and that this association is partly 
the result of friend relationship quality. Moreover, patients 
whose depressive symptoms improved more during treatment 
experienced friend and partner relationships characterized 
by more support and less stress, which, in turn, raised the 
likelihood of long-term abstinence. Further work is needed 
to guide our understanding of the full range of clinically 
relevant processes associated with depressive symptoms, 
partner and friend relationships, and abstinence.
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